Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Evaluating sexual function among women after recurrent pelvic organ prolapse transvaginal mesh repair

S. Tvarozek, M. Huser, M. Dostalova, M. Szypulova, I. Horvath

. 2022 ; 42 (8) : 3666-3671. [pub] 20221208

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010756

We aimed to evaluate women's sexual function before and after pelvic organ prolapse (POP) surgery utilising light transvaginal mesh after a prior hysterectomy. Only sexually active women with recurrent cystocele stage 3-4 according to POP-Q, who had previously undergone vaginal hysterectomy with anterior native tissue repair without apical fixation, were enrolled in the study. Women with previous mesh implant POP surgery, persistent vaginal infection or pelvic inflammatory disease were excluded. All patients were surgically treated between 2012 and 2015 using single-incision transvaginal mesh Calistar A. Sexual function was evaluated before a surgery and two years postoperatively. The assessment was accomplished via the standardised validated Czech translation of PISQ-12SF questionnaire. For each patient, age, BMI and parity were monitored. Out of all (89) eligible patients, 48 patients met inclusion criteria and were subsequently enrolled in our study. Two years postoperatively, 31 women (79.5%) improved their PISQ-12 score; five (12.8%) had equivalent scores, and three patients (7.7%) reported lower scores. Overall PISQ-12 score was 37.1 ± 2.6 postoperatively with a 2.9 ± 2.3 statistically significant positive difference compared to the score preceding surgery. The majority of patients undergoing surgery using Calistar A experienced a significant improvement in sexual function.IMPACT STATEMENTWhat is already known on this subject? Pelvic organ prolapse has a significant impact on women's sexual functioning in an adverse manner. Mesh implant repair is associated with lower rates of prolapse awareness and prolapse re-operation; however, it is linked with safety concerns. One of these concerns is the negative impact on women's sexual function. Evaluative study results following sexual function among women with mesh implant transvaginal repair are contradictory.What do the results of this study add? The results showed, that contrary to finding some of the previous studies, transvaginal mesh implant use could benefit patients with previous native tissue POP surgery failure with a low risk of sexual function deterioration.What are the implications of these findings for clinical practice and/or further research? The study provides clinical data for vaginal mesh implants on women's sexual function in the mid-term outcome. These data can be crucial for selecting the right POP surgical technique and evaluating its benefits and risks.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010756
003      
CZ-PrNML
005      
20230801132622.0
007      
ta
008      
230718s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/01443615.2022.2153023 $2 doi
035    __
$a (PubMed)36476069
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tvarozek, Samuel $u Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000310476742
245    10
$a Evaluating sexual function among women after recurrent pelvic organ prolapse transvaginal mesh repair / $c S. Tvarozek, M. Huser, M. Dostalova, M. Szypulova, I. Horvath
520    9_
$a We aimed to evaluate women's sexual function before and after pelvic organ prolapse (POP) surgery utilising light transvaginal mesh after a prior hysterectomy. Only sexually active women with recurrent cystocele stage 3-4 according to POP-Q, who had previously undergone vaginal hysterectomy with anterior native tissue repair without apical fixation, were enrolled in the study. Women with previous mesh implant POP surgery, persistent vaginal infection or pelvic inflammatory disease were excluded. All patients were surgically treated between 2012 and 2015 using single-incision transvaginal mesh Calistar A. Sexual function was evaluated before a surgery and two years postoperatively. The assessment was accomplished via the standardised validated Czech translation of PISQ-12SF questionnaire. For each patient, age, BMI and parity were monitored. Out of all (89) eligible patients, 48 patients met inclusion criteria and were subsequently enrolled in our study. Two years postoperatively, 31 women (79.5%) improved their PISQ-12 score; five (12.8%) had equivalent scores, and three patients (7.7%) reported lower scores. Overall PISQ-12 score was 37.1 ± 2.6 postoperatively with a 2.9 ± 2.3 statistically significant positive difference compared to the score preceding surgery. The majority of patients undergoing surgery using Calistar A experienced a significant improvement in sexual function.IMPACT STATEMENTWhat is already known on this subject? Pelvic organ prolapse has a significant impact on women's sexual functioning in an adverse manner. Mesh implant repair is associated with lower rates of prolapse awareness and prolapse re-operation; however, it is linked with safety concerns. One of these concerns is the negative impact on women's sexual function. Evaluative study results following sexual function among women with mesh implant transvaginal repair are contradictory.What do the results of this study add? The results showed, that contrary to finding some of the previous studies, transvaginal mesh implant use could benefit patients with previous native tissue POP surgery failure with a low risk of sexual function deterioration.What are the implications of these findings for clinical practice and/or further research? The study provides clinical data for vaginal mesh implants on women's sexual function in the mid-term outcome. These data can be crucial for selecting the right POP surgical technique and evaluating its benefits and risks.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a chirurgické síťky $x škodlivé účinky $7 D013526
650    12
$a prolaps pánevních orgánů $x chirurgie $7 D056887
650    12
$a cystokéla $7 D052858
650    12
$a suburetrální pásky $x škodlivé účinky $7 D053825
650    _2
$a vagina $x chirurgie $7 D014621
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Huser, Martin $u Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic $u Department of Obstetrics and Gynecology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000224824819
700    1_
$a Dostalova, Martina $u Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000278038952
700    1_
$a Szypulova, Martina $u Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000154582139
700    1_
$a Horvath, Ivan $u Department of Obstetrics and Gynecology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00002860 $t Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology $x 1364-6893 $g Roč. 42, č. 8 (2022), s. 3666-3671
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36476069 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132618 $b ABA008
999    __
$a ok $b bmc $g 1963290 $s 1197021
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 42 $c 8 $d 3666-3671 $e 20221208 $i 1364-6893 $m Journal of obstetrics and gynaecology $n J Obstet Gynaecol $x MED00002860
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...